| 摘要 |
<p>The invention relates to medicine, in particular to neurology and pediatrics, and can be used to predict the risk of development of congenital pathology of the central nervous system in the fetus.The method, according to the invention, consists in that on the 49th…51st day of pregnancy in the blood serum of the pregnant is determined the amount of alpha-fetoprotein, fibronectin, plasma protein A associated with pregnancy and progesterone serum, at the same time in the case when alpha-fetoprotein is higher than 124 µg/L, fibronectin is higher than 400 mg/mL, plasma protein A associated with pregnancy is less than 0.17 mIU/ml and serum progesterone is higher than 90 nmol/L is predicted the risk of development of congenital pathology of the central nervous system.</p> |
